571-580 items (total 704)
Published on October 13, 2021
“Stand by me”?—120 Researchers Debate the Evolutionary Origins of Music—
Office of Communications and Public Relations
Published on October 11, 2021
Research on the Realities of Telework and Workers Amid the Spread of COVID-19 (Preliminary Report on the "5th Survey on the State of Teleworking")
Office of Communications and Public Relations
Published on October 11, 2021
Discovery of a Mechanism by Which the Immune System Utilizes Cholesterol Regulation to Resolve Inflammation—Hopes for the Development of New Treatments for Inflammatory Diseases
Office of Communications and Public Relations
Published on October 06, 2021
Fast Prediction of Secondary Structures for More Complex and Longer RNAs
Office of Communications and Public Relations
Published on October 05, 2021
Gut Microbiota-Derived Acetate Improves Hepatic Insulin Resistance and Suppresses Non-alcoholic Steatohepatitis (NASH) - Potential for Next-Generation NASH Therapies Targeting Gut Microbiota -
Office of Communications and Public Relations
Published on September 29, 2021
Keio University Ranked 56th Worldwide in the QS Graduate Employability Rankings 2022
Office of Communications and Public Relations
Published on September 27, 2021
Marine Dietary Fiber Alginic Acid Found to Suppress Metabolic Syndrome via Gut Microbiota—Hopes for Development of Preventive Measures by Improving the Gut Environment
Office of Communications and Public Relations
Published on September 27, 2021
Screening for Cervical Myelopathy with Hand Motion Analysis Using a Contactless Sensor: Estimating the Presence of the Disease with Machine Learning for Early Diagnosis and Treatment
Office of Communications and Public Relations
Published on September 24, 2021
Successful Transmission of World's First Error-Free POF (Plastic Optical Fiber) - A Breakthrough Solution for Heat, Latency, and Cost Issues in Communication Systems -
Office of Communications and Public Relations
Published on September 21, 2021
Identifying Potential Candidates for Next-Generation Immune Checkpoint Inhibitor Therapy: Development of a Renal Cell Carcinoma Classification System Based on LAG-3, TIM-3, and TIGIT
Office of Communications and Public Relations